A new study published in the European Journal of Ophthalmology has found that a smartphone-based AI system demonstrated high accuracy in detecting major eye diseases including diabetic retinopathy, age-related macular degeneration and…
Mumbai-based healthtech startup Butterfly Learnings has raised Rs 65 crore ($7.7 million) in a pre-Series B funding round led by Inflexor Ventures. Existing investors Enzia Ventures, Insitor Impact Asia Fund and IIMA…
Sree Chitra Tirunal Institute for Medical Sciences and Technology has unveiled Chitra Core, its first coronary stent, at a conference in New Delhi. The polymer-coated Everolimus drug-eluting stent uses a Cobalt-Chromium alloy…
India's drug regulator has clarified that new drugs not yet approved anywhere in the world must undergo the full domestic regulatory process, even if Indian patients participated in global clinical trials. The…
The CBI has registered a corruption case against Bikash Roy, assistant drug controller at the CDSCO sub-zonal office in Visakhapatnam, and H Vikram, managing director of Artura Pharmaceuticals, over an alleged bribery…
The Union health ministry has invited applications for the post of Drugs Controller General of India (DCGI) to head the Central Drugs Standard Control Organisation (CDSCO). The move follows an April 2026…
Eisai has launched Leqembi, or lecanemab, in India for patients with mild cognitive impairment and mild dementia caused by early Alzheimer’s disease, after receiving marketing authorisation from the Central Drugs Standard Control…
The Centre told Parliament that India's drug regulator CDSCO does not use AI for regulatory approvals, relying instead on scientific and technical review. Separately, CDSCO issued guidance for AI-enabled medical device software,…
